RFC
IBB icon

Regions Financial Corp’s iShares Biotechnology ETF IBB Stock Holding History

Regions Financial Corp’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$894K Sell
4,701
-247
-5% -$42.5K 0.01% 513
2026
Q1 		$835K Sell
4,948
-159
-3% -$27.2K 0.01% 515
2025
Q4 		$862K Buy
5,107
+180
+4% +$29.2K 0.01% 506
2025
Q3 		$711K Buy
4,927
+294
+6% +$40.1K ﹤0.01% 555
2025
Q2 		$586K Sell
4,633
-827
-15% -$102K ﹤0.01% 580
2025
Q1 		$698K Sell
5,460
-402
-7% -$54.5K 0.01% 529
2024
Q4 		$775K Sell
5,862
-322
-5% -$45.3K 0.01% 515
2024
Q3 		$900K Sell
6,184
-427
-6% -$61.8K 0.01% 510
2024
Q2 		$907K Buy
6,611
+136
+2% +$18.2K 0.01% 491
2024
Q1 		$889K Sell
6,475
-457
-7% -$62.4K 0.01% 508
2023
Q4 		$942K Sell
6,932
-210
-3% -$25.6K 0.01% 484
2023
Q3 		$873K Sell
7,142
-564
-7% -$71.7K 0.01% 478
2023
Q2 		$978K Sell
7,706
-378
-5% -$49.1K 0.01% 475
2023
Q1 		$1.04M Sell
8,084
-845
-9% -$111K 0.01% 469
2022
Q4 		$1.17M Sell
8,929
-52
-0.6% -$6.72K 0.01% 444
2022
Q3 		$1.05M Sell
8,981
-375
-4% -$46.6K 0.01% 456
2022
Q2 		$1.1M Sell
9,356
-620
-6% -$73.6K 0.01% 457
2022
Q1 		$1.3M Sell
9,976
-709
-7% -$92.4K 0.01% 460
2021
Q4 		$1.63M Buy
10,685
+1,307
+14% +$202K 0.01% 425
2021
Q3 		$1.52M Buy
9,378
+79
+0.8% +$13.3K 0.01% 410
2021
Q2 		$1.52M Sell
9,299
-331
-3% -$51K 0.01% 410
2021
Q1 		$1.45M Sell
9,630
-116
-1% -$18.4K 0.01% 400
2020
Q4 		$1.48M Sell
9,746
-2,073
-18% -$296K 0.01% 372
2020
Q3 		$1.6M Buy
11,819
+3,752
+47% +$509K 0.02% 335
2020
Q2 		$1.1M Buy
8,067
+341
+4% +$43.5K 0.01% 394
2020
Q1 		$833K Buy
7,726
+1,638
+27% +$189K 0.01% 409
2019
Q4 		$734K Sell
6,088
-490
-7% -$54.7K 0.01% 476
2019
Q3 		$654K Sell
6,578
-885
-12% -$92.6K 0.01% 483
2019
Q2 		$814K Sell
7,463
-23
-0.3% -$2.45K 0.01% 444
2019
Q1 		$837K Sell
7,486
-1,366
-15% -$150K 0.01% 437
2018
Q4 		$854K Buy
8,852
+1
+0% +$106 0.01% 418
2018
Q3 		$1.08M Buy
8,851
+363
+4% +$42.7K 0.01% 414
2018
Q2 		$932K Sell
8,488
-1,178
-12% -$126K 0.01% 432
2018
Q1 		$1.03M Sell
9,666
-559
-5% -$62K 0.01% 414
2017
Q4 		$1.09M Buy
10,225
+1,594
+18% +$170K 0.01% 410
2017
Q3 		$960K Sell
8,631
-1,290
-13% -$138K 0.01% 439
2017
Q2 		$1.02M Sell
9,921
-60
-0.6% -$5.91K 0.01% 433
2017
Q1 		$975K Buy
9,981
+2,787
+39% +$267K 0.01% 507
2016
Q4 		$636K Sell
7,194
-1,809
-20% -$165K 0.01% 605
2016
Q3 		$869K Buy
9,003
+180
+2% +$17.1K 0.01% 530
2016
Q2 		$757K Sell
8,823
-900
-9% -$80.8K 0.01% 548
2016
Q1 		$846K Buy
9,723
+1,152
+13% +$103K 0.01% 533
2015
Q4 		$967K Sell
8,571
-240
-3% -$26K 0.01% 503
2015
Q3 		$891K Buy
8,811
+2,967
+51% +$356K 0.01% 515
2015
Q2 		$718K Buy
5,844
+588
+11% +$70.4K 0.01% 572
2015
Q1 		$602K Buy
5,256
+117
+2% +$12.9K 0.01% 607
2014
Q4 		$520K Buy
5,139
+624
+14% +$60.6K 0.01% 647
2014
Q3 		$411K Buy
4,515
+600
+15% +$52.7K 0.01% 834
2014
Q2 		$336K Buy
3,915
+420
+12% +$33.1K ﹤0.01% 910
2014
Q1 		$275K Buy
3,495
+195
+6% +$16.2K ﹤0.01% 958
2013
Q4 		$250K Buy
+3,300
New +$234K ﹤0.01% 983

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Regions Financial Corp's IBB Position: Q2 2026 in Review

Regions Financial Corp reduced its iShares Biotechnology ETF (IBB) stake by 5% in Q2 2026, selling an estimated $42.5K and leaving 4,701 shares worth $894K. The position accounts for 0.01% of the portfolio, ranked #513.

Regions Financial Corp first reported a position in IBB in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.63M in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Regions Financial Corp held 4,701 shares of iShares Biotechnology ETF worth $894K as of Q2 2026.
  • Regions Financial Corp sold 247 iShares Biotechnology ETF shares in Q2 2026, an estimated $42.5K.
  • iShares Biotechnology ETF made up 0.01% of Regions Financial Corp's portfolio in Q2 2026, its #513 holding.
  • Regions Financial Corp first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 51 quarters since.
  • Regions Financial Corp's iShares Biotechnology ETF position peaked at $1.63M in Q4 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.